This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Generation of human myogenic progenitors from pluripotent stem cells for in vivo regeneration
Cellular and Molecular Life Sciences Open Access 08 July 2022
-
Pax3-induced expansion enables the genetic correction of dystrophic satellite cells
Skeletal Muscle Open Access 26 October 2015
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Birmingham, K. Controversial muscular dystrophy therapy goes to court. Nature Med. 3, 1058 (1997).
Birmingham, K. FDA reprimands muscular dystrophy clinic. Nature Med. 4, 10 (1998).
Partridge, T.A. et al. Meeting of the Cell Transplantation Society in Miami [letter; comment]. Cell Transplant. 6, 195 –198 (1997).
Law, P.K. et al. Dystrophin production induced by myoblast transfer therapy in Duchenne muscular dystrophy [letter]. Lancet 336, 114–115 (1990).
Law, P.K. et al. Human gene therapy with myoblast transfer. Transplant. Proc. 29, 2234–2237 ( 1997).
Nicholson, L.V., Johnson, M.A., Bushby, K.M. & Gardner Medwin, D. Functional significance of dystrophin positive fibres in Duchenne muscular dystrophy. Arch. Dis. Child. 68, 632– 636 (1993).
Mendell, J.R. et al. Myoblast transfer in the treatment of Duchenne's muscular dystrophy. N. Engl. J. Med. 333, 832– 838 (1995).
Thanh, L.T., Man, N., Helliwell, T.R. & Morris, G.E. Characterization of revertant muscle fibers in Duchenne muscular dystrophy, using exon-specific monoclonal antibodies against dystrophin. Am. J. Hum. Genet. 56, 725–731 (1995).
Sherratt, T.G., Vulliamy, T. & Strong, P.N. Evolutionary conservation of the dystrophin central rod domain. Biochem J 287, 755– 759 (1992).
Hoffman, E.P., Morgan, J.E., Watkins, S.C. & Partridge, T. A Somatic reversion/suppression of the mouse mdx phenotype in vivo. J. Neurol. Sci. 99, 9– 25 (1990).
Acknowledgements
The authors acknowledge the support of the Muscular Dystrophy Group of Great Britain, The Leopold Muller Foundation, The Medical Research Council and the Parent Project for Duchenne Muscular Dystrophy Research.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Partridge, T., Lu, Q., Morris, G. et al. Is myoblast transplantation effective?. Nat Med 4, 1208–1209 (1998). https://doi.org/10.1038/3167
Issue Date:
DOI: https://doi.org/10.1038/3167
This article is cited by
-
Generation of human myogenic progenitors from pluripotent stem cells for in vivo regeneration
Cellular and Molecular Life Sciences (2022)
-
Pax3-induced expansion enables the genetic correction of dystrophic satellite cells
Skeletal Muscle (2015)
-
Functional skeletal muscle regeneration from differentiating embryonic stem cells
Nature Medicine (2008)
-
The Therapeutic Potential of Embryonic and Adult Stem Cells for Skeletal Muscle Regeneration
Stem Cell Reviews (2008)
-
Apoptosis coincident with the differentiation of skeletal myoblasts is delayed by caspase 3 inhibition and abrogated by MEK-independent constitutive Ras signaling
Cell Death & Differentiation (2002)